| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | +9.9% |
| Cost of Revenue | $811K | +3.4% |
| Gross Profit | $2.1M | +12.6% |
| R&D Expense | $5.2M | -40.3% |
| SG&A Expense | $4.0M | -5.3% |
| Operating Income | -$14.0M | -5.2% |
| Pre-tax Income | -$11.0M | -33.5% |
| Net Income | -$11.0M | -33.5% |
| EPS (Basic) | -$14.87 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | +7.7% |
| Accounts Receivable | $196K | -71.4% |
| Inventory | $502K | -58.9% |
| Current Assets | $4.8M | -13.8% |
| Total Assets | $9.4M | -38.7% |
| Current Liabilities | $2.0M | -31.8% |
| Total Liabilities | $5.5M | -16.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | +38.8% |
| Capital Expenditures | $690K | +30.2% |
| Investing Cash Flow | -$194K | +61.3% |
| Financing Cash Flow | $9.1M | -22.3% |
| Free Cash Flow | -$9.3M | +36.3% |
| -569.8% |
| EPS (Diluted) | -$15.19 | -385.3% |
| Stockholders' Equity |
| $3.9M |
| -55.6% |